Dermapharm Holding SE banner

Dermapharm Holding SE
DUS:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
DUS:DMP
Watchlist
Price: 46.45 EUR 1.86% Market Closed
Market Cap: €4.9B

Profitability Summary

Dermapharm Holding SE's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Dermapharm Holding SE

Margins Comparison
Dermapharm Holding SE Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Dermapharm Holding SE
XETRA:DMP
2.3B EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
879.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
295.2B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
116.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Dermapharm Holding SE Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Dermapharm Holding SE
XETRA:DMP
2.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
879.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
295.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
116.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Dermapharm Holding SE

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett